首页 > 最新文献

Laeknabladid最新文献

英文 中文
[The new collective bargaining agreement for doctors from the perspective of the Primary Healthcare in the Capital Area?] [从首都地区基层医疗看新的医生劳资协议?]]
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-01 DOI: 10.17992/lbl.2025.05.838
Nanna S Kristinsdottir
{"title":"[The new collective bargaining agreement for doctors from the perspective of the Primary Healthcare in the Capital Area?]","authors":"Nanna S Kristinsdottir","doi":"10.17992/lbl.2025.05.838","DOIUrl":"https://doi.org/10.17992/lbl.2025.05.838","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 5","pages":"209"},"PeriodicalIF":0.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144095590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Acute stroke treatment in Landspitali University hospital - current status and future aims]. 兰德斯皮塔利大学医院急性脑卒中治疗现状与未来目标。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.17992/lbl.2025.04.835
Bjorn Logi Thorarinsson, Marianne Klinke, Olafur Arni Sveinsson

Background: Advances in acute stroke care including specialized stroke units, intraveneous thrombolysis and mechanical thrombectomy for ischemic stroke, and prompt blood pressure reduction in intracerebral hemorrhage, have significantly reduced its devasting consequences. This study investigates acute stroke care quality at Landspitali University Hospital in Iceland (LUH).

Method: Retrospective, cross-sectional study describing the cohort of stroke patients seeking emergency treatment at LUH in 2022, comparing the quality of provided treatment to benchmarks set in neighbouring countries.

Results: Among 337 adult ischemic strokes and 71 intracerebral hemorrhages, the mean age was 70,7 (SD: 14,4); 72,6% arrived to LUH within six hours of onset. Baseline NIHSS was documented in 29,8% and 24,3% received a CT scan within15 minutes. Revascularisation therapy was given to 17,8% of ischemic strokes. Median door-to-needle and door-to-puncture times were 31 and 93 minutes with thrombolysis and thrombectomy, respectively; 69% of thrombectomies achieved a good reperfusion grade (mTICI 2b-3). In cases of intracerebral hemorrhage, 57,9% had documented systolic blood pressure targets, with 36,0% aiming for <160 mmHg and 17,2% for <140 mmHg. Anticoagulation was associated with 19,7% of these hemorrhages, of which 66,7% received reversal treatment. In all, 67,0% of ischemic stroke cases and 57,7% of intracerebral hemorrhages were admitted to a Neurology department, with a median admission time of 7,82 hours. Additionally, 19,6% of ischemic stroke cases were referred to a TIA/stroke outpatient clinic.

Conclusion: The hospital met benchmarks in thrombectomy rates and nearly in door-to-needle time in thrombolysis. There is room for improvement in other areas. The results can be used to support further enhancement of acute stroke treatment in Iceland and as a basis for policy development.

背景:急性中风护理方面的进步,包括专门的中风科室、针对缺血性中风的静脉溶栓和机械取栓术,以及针对脑内出血的及时降压,大大降低了中风的严重后果。本研究调查了冰岛兰茨皮塔利大学医院(Landspitali University Hospital,LUH)的急性中风护理质量:方法:回顾性横断面研究,描述 2022 年在冰岛兰茨皮塔利大学医院寻求急诊治疗的中风患者队列,将所提供的治疗质量与邻国设定的基准进行比较:结果:在337名成人缺血性中风患者和71名脑出血患者中,平均年龄为70.7岁(SD:14.4);72.6%的患者在发病6小时内到达路德维希医院。29.8%的患者有NIHSS基线记录,24.3%的患者在15分钟内接受了CT扫描。17.8%的缺血性脑卒中患者接受了血管重建治疗。溶栓和血栓切除术的 "从进针到进针 "和 "从进针到穿刺 "的中位时间分别为31分钟和93分钟;69%的血栓切除术达到了良好的再灌注等级(mTICI 2b-3)。在脑出血病例中,57.9%的患者有记录的收缩压目标,其中36.0%的患者以结论为目标:医院在血栓切除率方面达到了基准,在溶栓的 "门到针 "时间方面也接近基准。其他方面仍有改进空间。研究结果可用于进一步加强冰岛的急性中风治疗,并作为制定政策的依据。
{"title":"[Acute stroke treatment in Landspitali University hospital - current status and future aims].","authors":"Bjorn Logi Thorarinsson, Marianne Klinke, Olafur Arni Sveinsson","doi":"10.17992/lbl.2025.04.835","DOIUrl":"10.17992/lbl.2025.04.835","url":null,"abstract":"<p><strong>Background: </strong>Advances in acute stroke care including specialized stroke units, intraveneous thrombolysis and mechanical thrombectomy for ischemic stroke, and prompt blood pressure reduction in intracerebral hemorrhage, have significantly reduced its devasting consequences. This study investigates acute stroke care quality at Landspitali University Hospital in Iceland (LUH).</p><p><strong>Method: </strong>Retrospective, cross-sectional study describing the cohort of stroke patients seeking emergency treatment at LUH in 2022, comparing the quality of provided treatment to benchmarks set in neighbouring countries.</p><p><strong>Results: </strong>Among 337 adult ischemic strokes and 71 intracerebral hemorrhages, the mean age was 70,7 (SD: 14,4); 72,6% arrived to LUH within six hours of onset. Baseline NIHSS was documented in 29,8% and 24,3% received a CT scan within15 minutes. Revascularisation therapy was given to 17,8% of ischemic strokes. Median door-to-needle and door-to-puncture times were 31 and 93 minutes with thrombolysis and thrombectomy, respectively; 69% of thrombectomies achieved a good reperfusion grade (mTICI 2b-3). In cases of intracerebral hemorrhage, 57,9% had documented systolic blood pressure targets, with 36,0% aiming for <160 mmHg and 17,2% for <140 mmHg. Anticoagulation was associated with 19,7% of these hemorrhages, of which 66,7% received reversal treatment. In all, 67,0% of ischemic stroke cases and 57,7% of intracerebral hemorrhages were admitted to a Neurology department, with a median admission time of 7,82 hours. Additionally, 19,6% of ischemic stroke cases were referred to a TIA/stroke outpatient clinic.</p><p><strong>Conclusion: </strong>The hospital met benchmarks in thrombectomy rates and nearly in door-to-needle time in thrombolysis. There is room for improvement in other areas. The results can be used to support further enhancement of acute stroke treatment in Iceland and as a basis for policy development.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 4","pages":"166-174"},"PeriodicalIF":0.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clostridioides difficile Infections at Landspitali - timely revie]. [陆地医院艰难梭菌感染-及时回顾]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.17992/lbl.2025.04.833
Erna Milunka Kojic
{"title":"[Clostridioides difficile Infections at Landspitali - timely revie].","authors":"Erna Milunka Kojic","doi":"10.17992/lbl.2025.04.833","DOIUrl":"https://doi.org/10.17992/lbl.2025.04.833","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 4","pages":"157"},"PeriodicalIF":0.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clostridioides difficile infections at Landspítali University Hospital 2017-2022]. [2017-2022年Landspítali大学医院难辨梭菌感染]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.17992/lbl.2025.04.834
Arnar Thor Sigtryggsson, Kristjan Orri Helgason, Agnar Bjarnason, Magnus Gottfredsson

Objective: To investigate the epidemiology, severity, treatment, and prognosis of patients with C. difficile infections (CDI) diagnosed at Landspítali University Hospital from 2017-2022.

Materials and methods: The study population consisted of adult patients at Landspítali with double-positive (PCR + ELISA) diagnostic tests. If the same patient had two or more positive samples within a 28-day period, they were considered to reflect the same infection, and the latter samples were excluded.

Results: Overall, 358 CDI were identified in 301 patients. The majority of cases were diagnosed in women (59.5%). The incidence of healthcare-associated CDI was 3.23 infections/10.000 in-hospital days (range 2.65 - 3.26). Incidence of community-associated CDI was 0.57 infections/10.000 inhabitants of the Reykjavik metropolitan area. Incidence was positively correlated with increasing age and remained similar throughout the study period. The recurrence rate during the study period was 15.3% with a mean follow-up period of 1.6 person-years. At least 85.5% of patients had taken antibiotics within a month before diagnosis, most commonly from the penicillin class (57.8%), followed by cephalosporins (51.5%). More than half (54.7%) of patients had taken proton pump inhibitors preceding diagnosis. Metronidazole was the most common initial treatment (63.0%). Of these, 29.4% of cases required further treatment within 28 days of treatment start. Fecal microbiota transplantation was performed in 13 cases. The 30-day all-cause mortality rate was 7.3%.

Conclusions: The incidence of CDI at Landspítali has remained stable and comparable to what has been reported in Europe during the same period. Most patients had one or more risk factors present. Most received antibiotics as treatment, most commonly metronidazole. The results of this study indicate that incidence and clinical presentation of CDI in Iceland are stable, whilst novel treatment options look promising.

目的:了解2017-2022年Landspítali大学医院诊断的艰难梭菌感染(CDI)患者的流行病学、严重程度、治疗及预后。材料和方法:研究人群为在Landspítali进行双阳性(PCR + ELISA)诊断试验的成年患者。如果同一患者在28天内有两个或两个以上的阳性样本,则认为它们反映了相同的感染,后者的样本被排除在外。结果:301例患者共发现358例CDI。大多数病例被诊断为女性(59.5%)。与医疗保健相关的CDI发生率为3.23例感染/ 10,000个住院日(范围2.65 - 3.26)。雷克雅未克大都市区社区相关CDI发病率为0.57 / 10000名居民。发病率与年龄增长呈正相关,并在整个研究期间保持相似。研究期间复发率为15.3%,平均随访时间为1.6人年。至少85.5%的患者在诊断前一个月内服用过抗生素,最常见的是青霉素类(57.8%),其次是头孢菌素类(51.5%)。超过一半(54.7%)的患者在诊断前曾服用质子泵抑制剂。甲硝唑是最常见的初始治疗(63.0%)。其中,29.4%的病例需要在开始治疗的28天内进一步治疗。13例患者行粪便菌群移植。30天全因死亡率为7.3%。结论:Landspítali的CDI发病率保持稳定,与同期欧洲报道的发病率相当。大多数患者存在一种或多种危险因素。大多数人接受抗生素治疗,最常见的是甲硝唑。这项研究的结果表明,冰岛CDI的发病率和临床表现是稳定的,而新的治疗方案看起来很有希望。
{"title":"[Clostridioides difficile infections at Landspítali University Hospital 2017-2022].","authors":"Arnar Thor Sigtryggsson, Kristjan Orri Helgason, Agnar Bjarnason, Magnus Gottfredsson","doi":"10.17992/lbl.2025.04.834","DOIUrl":"10.17992/lbl.2025.04.834","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the epidemiology, severity, treatment, and prognosis of patients with C. difficile infections (CDI) diagnosed at Landspítali University Hospital from 2017-2022.</p><p><strong>Materials and methods: </strong>The study population consisted of adult patients at Landspítali with double-positive (PCR + ELISA) diagnostic tests. If the same patient had two or more positive samples within a 28-day period, they were considered to reflect the same infection, and the latter samples were excluded.</p><p><strong>Results: </strong>Overall, 358 CDI were identified in 301 patients. The majority of cases were diagnosed in women (59.5%). The incidence of healthcare-associated CDI was 3.23 infections/10.000 in-hospital days (range 2.65 - 3.26). Incidence of community-associated CDI was 0.57 infections/10.000 inhabitants of the Reykjavik metropolitan area. Incidence was positively correlated with increasing age and remained similar throughout the study period. The recurrence rate during the study period was 15.3% with a mean follow-up period of 1.6 person-years. At least 85.5% of patients had taken antibiotics within a month before diagnosis, most commonly from the penicillin class (57.8%), followed by cephalosporins (51.5%). More than half (54.7%) of patients had taken proton pump inhibitors preceding diagnosis. Metronidazole was the most common initial treatment (63.0%). Of these, 29.4% of cases required further treatment within 28 days of treatment start. Fecal microbiota transplantation was performed in 13 cases. The 30-day all-cause mortality rate was 7.3%.</p><p><strong>Conclusions: </strong>The incidence of CDI at Landspítali has remained stable and comparable to what has been reported in Europe during the same period. Most patients had one or more risk factors present. Most received antibiotics as treatment, most commonly metronidazole. The results of this study indicate that incidence and clinical presentation of CDI in Iceland are stable, whilst novel treatment options look promising.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 4","pages":"158-165"},"PeriodicalIF":0.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The way forward in stroke treatment]. [中风治疗的发展方向]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.17992/lbl.2025.04.832
Anna Bryndis Einarsdottir
{"title":"[The way forward in stroke treatment].","authors":"Anna Bryndis Einarsdottir","doi":"10.17992/lbl.2025.04.832","DOIUrl":"https://doi.org/10.17992/lbl.2025.04.832","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 4","pages":"155"},"PeriodicalIF":0.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Elderly woman with a history of stroke and a mass in the aortic root. Papillary fibroelastoma. - Case report]. 老年妇女,有中风史,主动脉根部有肿块。乳头状fibroelastoma。—病例报告]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-04-01 DOI: 10.17992/lbl.2025.04.836
Matthias Loeve, Steinar Gudmundsson, Tomas Gudbjartsson

Introduction: A woman in her mid-seventies with a history of chronic atrial fibrillation (AF), coronary artery disease, polymyalgia rheumatica, and type 2 diabetes was found in a semi-comatose state in her home. In the emergency room, she presented with left arm weakness and aphasia. Magnetic resonance imaging of the brain revealed multiple acute infarcts attributed to cardiac emboli, although transthoracic echocardiography (TTE) did not detect cardiac thrombi. Following extensive rehabilitation, she was readmitted with chest pain and dyspnea, which were thought to be related to a bradycardia-induced heart failure. She received a pacemaker, but her clinical state did not improve. Therefore, cardioversion of her AF was planned; however, prior to the procedure, transesophageal echocardiography (TEE) revealed a mass in the aortic root. The mass, which was attached to the non-coronary aortic valve cusp, was surgically removed via open-heart surgery, and the valve was repaired to prevent aortic insufficiency. The patient fared well postoperatively. Histological analysis confirmed papillary fibroelastoma, which is the third most common benign heart tumor after myxoma and lipoma. This case, which is the first documented report of a papillary fibroelastoma of the aortic valve in Iceland, demonstrates the importance of considering cardiac tumors in patients with embolic stroke.

简介:一名70多岁的女性,有慢性心房颤动(AF)、冠状动脉疾病、风湿性多肌痛和2型糖尿病病史,在家中被发现处于半昏迷状态。在急诊室,她出现了左臂无力和失语。尽管经胸超声心动图(TTE)未发现心脏血栓,但脑磁共振成像显示心脏栓塞引起的多发性急性梗死。经过广泛的康复治疗后,她因胸痛和呼吸困难再次入院,这被认为与心动过缓引起的心力衰竭有关。她接受了心脏起搏器,但她的临床状况没有改善。因此,我们计划对她进行心房颤动复律;然而,在手术前,经食管超声心动图(TEE)显示主动脉根部有肿块。该肿块附着于非冠状动脉主动脉瓣尖,通过心内直视手术切除,并修复瓣膜以防止主动脉功能不全。病人术后情况良好。组织学分析证实乳头状纤维弹性瘤是继黏液瘤和脂肪瘤之后第三常见的心脏良性肿瘤。该病例是冰岛主动脉瓣乳头状纤维弹性瘤的首例文献报道,表明栓塞性卒中患者考虑心脏肿瘤的重要性。
{"title":"[Elderly woman with a history of stroke and a mass in the aortic root. Papillary fibroelastoma. - Case report].","authors":"Matthias Loeve, Steinar Gudmundsson, Tomas Gudbjartsson","doi":"10.17992/lbl.2025.04.836","DOIUrl":"10.17992/lbl.2025.04.836","url":null,"abstract":"<p><strong>Introduction: </strong>A woman in her mid-seventies with a history of chronic atrial fibrillation (AF), coronary artery disease, polymyalgia rheumatica, and type 2 diabetes was found in a semi-comatose state in her home. In the emergency room, she presented with left arm weakness and aphasia. Magnetic resonance imaging of the brain revealed multiple acute infarcts attributed to cardiac emboli, although transthoracic echocardiography (TTE) did not detect cardiac thrombi. Following extensive rehabilitation, she was readmitted with chest pain and dyspnea, which were thought to be related to a bradycardia-induced heart failure. She received a pacemaker, but her clinical state did not improve. Therefore, cardioversion of her AF was planned; however, prior to the procedure, transesophageal echocardiography (TEE) revealed a mass in the aortic root. The mass, which was attached to the non-coronary aortic valve cusp, was surgically removed via open-heart surgery, and the valve was repaired to prevent aortic insufficiency. The patient fared well postoperatively. Histological analysis confirmed papillary fibroelastoma, which is the third most common benign heart tumor after myxoma and lipoma. This case, which is the first documented report of a papillary fibroelastoma of the aortic valve in Iceland, demonstrates the importance of considering cardiac tumors in patients with embolic stroke.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 4","pages":"175-177"},"PeriodicalIF":0.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143755586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Improved glycemic control of children and youth with type 1 diabetes in Iceland in 2008-2022]. [2008-2022年冰岛1型糖尿病儿童和青少年血糖控制改善]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.17992/lbl.2025.03.830
Jakob Thorir Hansen, Elisabet Konradsdottir, Ragnar Bjarnason, Berglind Jonsdottir

Introduction: Type 1 diabetes is characterized by destruction of the insulin-producing beta cells causing hyperglycemia. Insulin treatment targeting euglycemia mitigates complications. This study aims to assess glycemic control in Icelandic children with diabetes over the past 14 years and examine the impact of a semi-automatic insulin pump.

Methods: The study included Icelandic pediatric patients with type 1 diabetes from the past 14 years. Data on HbA1c, date of diagnosis, co-occurring diagnoses, sex, age, number of ketoacidosis diagnoses, and the introduction of a semi-automatic insulin pump were gathered from medical records.

Results: The average of means HbA1c peaked in 2012 at 70,4±11,3 mmol/mol and had its nadir in 2022 at 59,5±11,2 mmol/mol. The proportion of children with HbA1c over 70 mmol/mol was highest in 2011 (51.8%) and lowest in 2022 (10.2%). Females had higher HbA1c levels, the difference decreased by the end of the study period. Mean HbA1c decreased by 6.4 mmol/mol 18 months after introduction of a semi-automatic insulin pump. There was no significant change in mean HbA1c when 18 months prior and post introduction were compared. No change in incidence was observed over the period. Between 2018-2023, 11.2% had hypothyroidism, 2.2% had celiac disease, and 29 cases of ketoacidosis were diagnosed.

Discussion: Significant progress has been made in treating Icelandic children with type 1 diabetes in recent years. There was no increase in incidence, contrary to other studies. The impact of the semi-automatic insulin pump was less pronounced than in other studies, possibly due to a longer follow-up period.

1型糖尿病的特点是产生胰岛素的β细胞被破坏导致高血糖。针对血糖正常的胰岛素治疗可减轻并发症。本研究旨在评估过去14年来冰岛糖尿病儿童的血糖控制情况,并检查半自动胰岛素泵的影响。方法:该研究纳入了过去14年冰岛1型糖尿病患儿。从医疗记录中收集HbA1c、诊断日期、合并诊断、性别、年龄、酮症酸中毒诊断次数和引入半自动胰岛素泵的数据。结果:HbA1c均值在2012年达到峰值,为70,4±11,3 mmol/mol,在2022年达到最低点,为59,5±11,2 mmol/mol。HbA1c超过70 mmol/mol的儿童比例在2011年最高(51.8%),在2022年最低(10.2%)。女性患者的HbA1c水平较高,但在研究结束时差异减小。引入半自动胰岛素泵18个月后,平均HbA1c降低6.4 mmol/mol。比较前后18个月的平均HbA1c无显著变化。在此期间没有观察到发病率的变化。2018-2023年期间,11.2%的人患有甲状腺功能减退症,2.2%的人患有乳糜泻,29例被诊断为酮症酸中毒。讨论:近年来,冰岛在治疗1型糖尿病儿童方面取得了重大进展。与其他研究相反,发病率没有增加。半自动胰岛素泵的影响没有其他研究那么明显,可能是由于随访时间较长。
{"title":"[Improved glycemic control of children and youth with type 1 diabetes in Iceland in 2008-2022].","authors":"Jakob Thorir Hansen, Elisabet Konradsdottir, Ragnar Bjarnason, Berglind Jonsdottir","doi":"10.17992/lbl.2025.03.830","DOIUrl":"10.17992/lbl.2025.03.830","url":null,"abstract":"<p><strong>Introduction: </strong>Type 1 diabetes is characterized by destruction of the insulin-producing beta cells causing hyperglycemia. Insulin treatment targeting euglycemia mitigates complications. This study aims to assess glycemic control in Icelandic children with diabetes over the past 14 years and examine the impact of a semi-automatic insulin pump.</p><p><strong>Methods: </strong>The study included Icelandic pediatric patients with type 1 diabetes from the past 14 years. Data on HbA1c, date of diagnosis, co-occurring diagnoses, sex, age, number of ketoacidosis diagnoses, and the introduction of a semi-automatic insulin pump were gathered from medical records.</p><p><strong>Results: </strong>The average of means HbA1c peaked in 2012 at 70,4±11,3 mmol/mol and had its nadir in 2022 at 59,5±11,2 mmol/mol. The proportion of children with HbA1c over 70 mmol/mol was highest in 2011 (51.8%) and lowest in 2022 (10.2%). Females had higher HbA1c levels, the difference decreased by the end of the study period. Mean HbA1c decreased by 6.4 mmol/mol 18 months after introduction of a semi-automatic insulin pump. There was no significant change in mean HbA1c when 18 months prior and post introduction were compared. No change in incidence was observed over the period. Between 2018-2023, 11.2% had hypothyroidism, 2.2% had celiac disease, and 29 cases of ketoacidosis were diagnosed.</p><p><strong>Discussion: </strong>Significant progress has been made in treating Icelandic children with type 1 diabetes in recent years. There was no increase in incidence, contrary to other studies. The impact of the semi-automatic insulin pump was less pronounced than in other studies, possibly due to a longer follow-up period.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 3","pages":"112-118"},"PeriodicalIF":0.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143517161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Operations for neuroendocrine tumors in upper gastrointestinal tract in Landspitali University Hospital-Reasearch]. 兰德斯皮塔利大学医院研究中心上胃肠道神经内分泌肿瘤的手术治疗
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.17992/lbl.2025.03.829
Erla Thordis Atladottir, Daniel Bjorn Yngvason, Kristin Huld Haraldsdottir

Introduction: Neuroendocrine tumors are rare tumors, originating from the neuroendocrine system. They originate most commonly in the lungs and gastrointestinal organs. These tumors differ according to their origin and maturity. Neuroendocrine tumors can be hormonally active or inactive.

Method: This is a retrospective study of patients that had surgery for a neuroendocrine tumor in the upper gastrointestinal organs, in the period 2010-2020. Tumor origin was registered, as well as operations and factors related to the operations, complications, and survival rate. Patients who underwent surgery for a primary tumor in the upper gastrointestinal tract, or liver metastasis were included. Data was gathered from medical charts from Landspitali University Hospital, and analyzed with descriptive and survival statistics with the help of the softwares Microsoft Excel and GraphPad Prism. Appropriate permits were gathered.

Results: In total, 31 patients, was operated for neuroendocrine tumors in the upper gastrointestinal tract but tumor resection was only done on 29 patients. Those 29 patients made the study sample. 34% of the patients had complications that required intervention or intensive care treatment. No patient died within 30 days of the operation. Total survival of the patients was 88% and disease specific survival was 95%.

Conclusion: Few patients are operated on for a neuroendocrine tumor in the upper gastrointestinal tract each year. The surgeries were successful, and survival is comparable to other studies.

神经内分泌肿瘤是一种罕见的肿瘤,起源于神经内分泌系统。它们最常起源于肺部和胃肠道器官。这些肿瘤因其起源和成熟程度不同而不同。神经内分泌肿瘤可以是激素活跃或不活跃的。方法:回顾性研究2010-2020年间上消化道神经内分泌肿瘤手术患者。记录肿瘤起源、手术及手术相关因素、并发症及生存率。因上消化道原发肿瘤或肝转移而接受手术的患者也包括在内。数据从Landspitali大学医院的病历中收集,使用Microsoft Excel和GraphPad Prism软件进行描述性统计和生存统计分析。获得了适当的许可。结果:31例上消化道神经内分泌肿瘤行手术治疗,29例行肿瘤切除术。这29名患者构成了研究样本。34%的患者出现并发症,需要干预或重症监护治疗。手术后30天内无患者死亡。患者总生存率为88%,疾病特异性生存率为95%。结论:每年手术治疗上消化道神经内分泌肿瘤的病例较少。手术很成功,生存率与其他研究相当。
{"title":"[Operations for neuroendocrine tumors in upper gastrointestinal tract in Landspitali University Hospital-Reasearch].","authors":"Erla Thordis Atladottir, Daniel Bjorn Yngvason, Kristin Huld Haraldsdottir","doi":"10.17992/lbl.2025.03.829","DOIUrl":"10.17992/lbl.2025.03.829","url":null,"abstract":"<p><strong>Introduction: </strong>Neuroendocrine tumors are rare tumors, originating from the neuroendocrine system. They originate most commonly in the lungs and gastrointestinal organs. These tumors differ according to their origin and maturity. Neuroendocrine tumors can be hormonally active or inactive.</p><p><strong>Method: </strong>This is a retrospective study of patients that had surgery for a neuroendocrine tumor in the upper gastrointestinal organs, in the period 2010-2020. Tumor origin was registered, as well as operations and factors related to the operations, complications, and survival rate. Patients who underwent surgery for a primary tumor in the upper gastrointestinal tract, or liver metastasis were included. Data was gathered from medical charts from Landspitali University Hospital, and analyzed with descriptive and survival statistics with the help of the softwares Microsoft Excel and GraphPad Prism. Appropriate permits were gathered.</p><p><strong>Results: </strong>In total, 31 patients, was operated for neuroendocrine tumors in the upper gastrointestinal tract but tumor resection was only done on 29 patients. Those 29 patients made the study sample. 34% of the patients had complications that required intervention or intensive care treatment. No patient died within 30 days of the operation. Total survival of the patients was 88% and disease specific survival was 95%.</p><p><strong>Conclusion: </strong>Few patients are operated on for a neuroendocrine tumor in the upper gastrointestinal tract each year. The surgeries were successful, and survival is comparable to other studies.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 3","pages":"106-111"},"PeriodicalIF":0.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143517166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Stroke and vegetations on cardiac valves - Case report]. [中风和心脏瓣膜上的植被- 1例报告]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.17992/lbl.2025.03.831
Sigrun Jonsdottir, Thorunn Jonsdottir, Olafur Arni Sveinsson

Introduction: Ischemic stroke is a common disease that can stem from multiple different causes, some of which are uncommon. A 43 year old woman with a history of systemic lupus erythematosus and antiphospholipid syndrome visited the emergency department due to dysarthria and was diagnosed with ischemic stroke. Transesophageal echocardiogram showed a mass on the mitral valve. After further workup, she was diagnosed with Libman-Sacks endocarditis, which is caused by endothelium damage along with hypercoagulability, and can form due to systemic lupus erythematosus or antiphospholipid syndrome. Libman-Sacks endocarditis is a nonbacterial thrombotic endocarditis and thromboembolism is rare. It is treated with anticoagulation. It is also important to treat the underlying cause of the endocarditis.

简介:缺血性中风是一种常见的疾病,可以由多种不同的原因引起,其中一些是不常见的。一名43岁女性,有系统性红斑狼疮及抗磷脂综合征病史,因构音障碍就诊急诊科,诊断为缺血性脑卒中。经食管超声心动图显示二尖瓣上有肿块。进一步检查后,她被诊断为Libman-Sacks心内膜炎,这是由内皮细胞损伤和高凝性引起的,可由系统性红斑狼疮或抗磷脂综合征形成。Libman-Sacks心内膜炎是一种非细菌性血栓性心内膜炎,血栓栓塞是罕见的。用抗凝剂治疗。治疗心内膜炎的根本原因也很重要。
{"title":"[Stroke and vegetations on cardiac valves - Case report].","authors":"Sigrun Jonsdottir, Thorunn Jonsdottir, Olafur Arni Sveinsson","doi":"10.17992/lbl.2025.03.831","DOIUrl":"10.17992/lbl.2025.03.831","url":null,"abstract":"<p><strong>Introduction: </strong>Ischemic stroke is a common disease that can stem from multiple different causes, some of which are uncommon. A 43 year old woman with a history of systemic lupus erythematosus and antiphospholipid syndrome visited the emergency department due to dysarthria and was diagnosed with ischemic stroke. Transesophageal echocardiogram showed a mass on the mitral valve. After further workup, she was diagnosed with Libman-Sacks endocarditis, which is caused by endothelium damage along with hypercoagulability, and can form due to systemic lupus erythematosus or antiphospholipid syndrome. Libman-Sacks endocarditis is a nonbacterial thrombotic endocarditis and thromboembolism is rare. It is treated with anticoagulation. It is also important to treat the underlying cause of the endocarditis.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 3","pages":"119-121"},"PeriodicalIF":0.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143517167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Living with type 1 diabetes]. [1型糖尿病患者]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-03-01 DOI: 10.17992/lbl.2025.03.828
Kolbeinn Gudmundsson
{"title":"[Living with type 1 diabetes].","authors":"Kolbeinn Gudmundsson","doi":"10.17992/lbl.2025.03.828","DOIUrl":"https://doi.org/10.17992/lbl.2025.03.828","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 3","pages":"105"},"PeriodicalIF":0.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143517163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laeknabladid
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1